Background & AimsChronic viral hepatitis is a leading cause of worldwide liver-related morbidity and mortality, despite the availability effective treatments that reduce or prevent complications in most patients. Electronic-health (eHealth) technologies have potential to intervene along whole cascade care. We aimed summarize available literature on eHealth interventions with respect conventiona...

Introduction Despite advancements in hepatitis C virus (HCV) infection treatment, HCV still represents a significant public health burden. Besides progressive hepatic damage, viral persistence has lasting effects on innate and adaptive immune responses. Lack of complete understanding the factors driving an effective response contributes to failure develop vaccine for prevention. This study adva...

Aim: Hepatitis B(HBV), C(HCV) and HIV infections are important parenterally transmitted infections. The aim of this study is to determine the seroprevalence HBsAg, anti-HBs, anti-HCV anti-HIV in patients with preoperative preparation.
 Materials MethodS: Anti-HBs, anti-HCV, tests chemiluminescent enzyme immune-assay method a total 900 applied General Surgery Clinic were evaluated preoperat...

Background: HBV and HCV infection, have been found to worsen the health of PLWAS, thereby impairing treatments management. HIV, HBV, are transmitted through similar routes hence presence infection with any them could be a risk factor for others. Objective: Determine prevalence HBV/HCV co-infection in persons HIV. Method: This was serological study For Hepatitis B surface antigen investigated an...

Introduction 
 This study aimed to reveal the utility of age-platelet (AP) index and aspartate aminotransferase (AST) alanine (ALT) ratio (AAR), which are non-invasive markers, in patients with chronic Hepatitis C virus (HCV) infection prediction fibrosis evaluate whether viral markers could be used for that purpose or not. Methods
 A total treatment-naïve 49 HCV who underwent liver b...

Summary Background The World Health Organization (WHO) set a goal to eliminate hepatitis C (HCV) infection globally by 2030, with specific targets reduce new viral infections 80% and related deaths 65%. However, an overlooked aspect that may hinder these efforts is the impact other liver diseases could have continuing drive disease progression offset beneficial of DAAs on end‐stage hepatocellul...

The resistance of hepatitis C virus (HCV) to direct-acting antiviral agents, used in chronic treatment, consists a natural process resulting from resistance-associated substitutions (RASs) at specific amino acid regions. To identify and establish the prevalence RASs NS3 gene patients with state Pará, northern Brazil. Molecular analysis was performed on total 35 infected HCV genotype 1, who were...

Abstract Successful clinical drug development requires rational design of combination treatments based on preclinical data. Anti-hepatitis C virus (HCV) drugs exhibit significant diversity in antiviral effect. Dose-response assessments can be used to determine parameters profiling the diverse effect during treatment. In current study, a combined experimental and mathematical approaches were com...

Hemophilia is the most common congenital coagulative disorder which exposes the patients to many problems because of lack of coagulative factors, higher risk of viral infections and other complications. This study was designed to detect the prevalence of hepatitis B and C infection in hemophiliac patients referring to Kerman Samenalhojaj Center. For this purpose, 97 hemophiliac patients were st...